ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lorviqua 25 mg, Filmtabletten - 90
66941003 Pfizer AG
Lorviqua 25 mg, Filmtabletten19.02.2020
  19.02.2020
Lorlatinib (L01ED05) 
WHO-DDD 
07.16.10.90
07.16.10. 
A  
Yes 
IPCI
3288.55Yes
    
10 %3592.90
  
7680669410032Synthetika
  
Composition
lorlatinibum 25 mg, cellulosum microcristallinum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum A corresp. natrium 0.315 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.575 mg, macrogolum 4000, triacetinum, E 171, E 172 (nigrum), E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Lorlatinibum25 mg
BAG: Active AgentDose
Lorlatinibum25 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Calcium Hydrogen Phosphate Dihydrate  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum Überzug
Lactose Monohydrate1.575 mg 
Macrogol4000  
Magnesii Stearas  
Pro Compresso Obducto  
Triacetinum  
 
Source
Data was imported : 04.04.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home